Longtime St. Jude Medical board member dies; Vascular device company Sapheon pulls in $8.6M;

 @FierceMedDev: Medtronic gained FDA approval and a CE mark for a new atrial fibrillation treatment. News | Follow @FierceMedDev

@MarkHFierce: LabCorp. says no, but analysts believe the company is a buyout target for private equity firms--via BloombergReport | Follow @MarkHFierce

 @DamianFierce: Bolstered by Myriad's court decision, Rosetta is expanding its capacity and soaring on the Street. More | Follow @DamianFierce

> St. Jude Medical ($STJ) board member Thomas Garrett, III died after a long battle against multiple myeloma. He joined the board of directors shortly after the company launched in 1979. Release

> Sapheon, a medical device company focused on treating vascular disease, has raised $8.6 million in what will eventually be an $18.5 million Series B round. Release

> Kips Bay Medical ($KIPS) has launched its U.S. feasibility trial in Europe for the company's eSVS Mesh coronary artery bypass grafting product. Meanwhile, the quest continues to gather additional information for the FDA to gain approval for a pivotal study. Release

> Flexicath gained FDA clearance for an updated catheter insertion system. Release

> The chief financial officer at Syneron Medical ($ELOS), an aesthetic device company, has resigned. Board member David Schlachet, a former Syneron CEO and CFO, will fill the slot until executives can find a permanent replacement. Release

Biotech News

 @FierceBiotech: New CEO tapped to run armed-antibody biotech Actinium. News | Follow @FierceBiotech

 @JohnCFierce: Talked yesterday with Andrea Pfeifer of AC Immune, working on a new Alzheimer's drug with Roche. Said: We've got to move to earlier stage. | Follow @JohnCFierce

 @RyanMFierce: A question now is how far will $LLY fall with sola failure, far enough for CEO John L. to change tune on internal R&D w/o mega-merger? | Follow @RyanMFierce

> Lilly's Alzheimer's drug solanezumab flunks out, but CEO sees promise. More

> Agennix slashes staff in wake of PhIII cancer drug disaster. Article

> Startup biotech hauls in $23M A round for antiviral work. Story

> Deadly tox threat kills Bristol-Myers' once-brilliant $2.5B hep C prospect. News

Pharma News

 @FiercePharma: Big Pharma again wins California price-fixing case. Report | Follow @FiercePharma

> Pfizer, Impax reach secret agreement on Detrol generic. Article

> Big Pharma does lousy job with mobile online sites. Item

> GSK's wind turbine plan blows, Scots suggest. Story

And Finally... This October, Patrick Kelly and Joanne Frogge will launch BidMed, an eBay-like company designed to help hospitals and health care systems sell, buy and trade refurbished medical equipment. Story

Suggested Articles

Boehringer Ingelheim tapped Healx to help identify new drug indications and leverage its AI to explore R&D options in neurological diseases.

CMR Surgical will have a new CEO at the top of the year, as it kicks off the global launch of its modular Versius system while awaiting FDA approval.

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.